Researchers at the UF Herbert Wertheim College of Engineering receive a grant from the National Science Foundation to study COVID-19 modeling, staffing and PPE.
When COVID-19 brought the tourism industry to a crashing halt this spring, farmers around the state quickly pivoted to sell the bounty of fruit and vegetables that were at peak harvest.
UF Researchers will begin evaluating whether hydroxychloroquine can prevent COVID-19 infections.
Students, staff and faculty get swabbed to check for potential COVID-19 infections. Beneath their feet, another testing system churns away, searching for the virus in UF’s wastewater.
As the physical and socioeconomic impacts of the COVID-19 pandemic continue to be explored by different experts, researchers at UF are using data from the past to establish a method for predicting the near-term economic impacts of the pandemic.
Families are beginning to ask more questions about when COVID-19 vaccines will be offered to children younger than 16, and...
University of Florida College of Pharmacy researchers studying the safety of two classes of drugs touted as potential therapeutics for COVID-19 report mixed results.
It’s a pandemic seemingly without end. The latest coronavirus variant is fueling a surge in cases while Americans worry about ever-more infectious versions to come. The daily news is filled with talk of sickness, overburdened health care providers and the struggle to mask and vaccinate a nation. It’s a recipe for a mental health crisis.
Researchers from across the University of Florida and UF Health have joined an urgent effort to collect and donate personal protective equipment, or PPE, to build upon existing stockpiles in support of clinical colleagues on the frontlines of treating COVID-19.
Infectious disease specialist and physician Kartikeya Cherabuddi, explains what medical doctors monitor and how they treat patients.
UF Health researchers begin developing an at-home test for coronavirus.
A national committee that includes a prominent University of Florida physician has recommended to federal and world leaders a four-phase approach to fairly allocate COVID-19 vaccines when they become available.